Data Insights

(Avibactam sodium + aztreonam) by AbbVie for Urinary Tract Infections: Likelihood of Approval

(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Urinary Tract Infections. According...

Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam Sodium + Aztreonam) in Urinary Tract Infections

Data Insights

(Avibactam sodium + aztreonam) by AbbVie for Gram-Negative Bacterial Infections: Likelihood of Approval

(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Gram-Negative Bacterial Infections. According...

Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam Sodium + Aztreonam) in Gram-Negative Bacterial Infections

Data Insights

(Avibactam sodium + aztreonam) by AbbVie for Complicated Intra-Abdominal Infections: Likelihood of Approval

(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Complicated Intra-Abdominal Infections. According...

Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam Sodium + Aztreonam) in Complicated Intra-Abdominal Infections

Data Insights

(Avibactam sodium + aztreonam) by AbbVie for Peritonitis: Likelihood of Approval

(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Peritonitis. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam Sodium + Aztreonam) in Peritonitis

Data Insights

(Avibactam sodium + aztreonam) by AbbVie for Bacterial Pneumonia: Likelihood of Approval

(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Bacterial Pneumonia. According to...

Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam Sodium + Aztreonam) in Bacterial Pneumonia

Data Insights

(Avibactam sodium + aztreonam) by Pfizer for Pyelonephritis: Likelihood of Approval

(Avibactam sodium + aztreonam) is under clinical development by Pfizer and currently in Phase III for Pyelonephritis. According to GlobalData,...

Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam Sodium + Aztreonam) in Pyelonephritis

Data Insights

(Avibactam sodium + aztreonam) by AbbVie for Ventilator Associated Pneumonia (VAP): Likelihood of Approval

(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Ventilator Associated Pneumonia (VAP)....

Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam Sodium + Aztreonam) in Ventilator Associated Pneumonia (VAP)

Data Insights

(Avibactam sodium + aztreonam) by AbbVie for Hospital Acquired Pneumonia (HAP): Likelihood of Approval

(Avibactam sodium + aztreonam) is under clinical development by AbbVie and currently in Phase III for Hospital Acquired Pneumonia (HAP)....

Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam Sodium + Aztreonam) in Hospital Acquired Pneumonia (HAP)